# AET09 variant 1 (AEs related to study drug by SMQ) is produced correctly

    Code
      res
    Output
                                                                                         Xanomeline High Dose   Placebo    Xanomeline Low Dose
                                                                                                (N=84)           (N=86)          (N=84)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event related to study drug           8 (9.5%)         3 (3.5%)        5 (6.0%)      
      SMQ1                                                                                                                                    
        Total number of patients with at least one adverse event related to study drug         8 (9.5%)         3 (3.5%)        5 (6.0%)      
        Total number of events related to study drug                                              18               5                9         
        NAUSEA                                                                                 5 (6.0%)         3 (3.5%)        3 (3.6%)      
        VOMITING                                                                               5 (6.0%)         2 (2.3%)        3 (3.6%)      

# AET09 variant 2 (AEs related to study drug by SMQ with customized queries) is produced correctly

    Code
      res
    Output
                                                                                         Xanomeline High Dose   Placebo    Xanomeline Low Dose
                                                                                                (N=84)           (N=86)          (N=84)       
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event related to study drug          11 (13.1%)        5 (5.8%)        7 (8.3%)      
      SMQ1                                                                                                                                    
        Total number of patients with at least one adverse event related to study drug         8 (9.5%)         3 (3.5%)        5 (6.0%)      
        Total number of events related to study drug                                              18               5                9         
        NAUSEA                                                                                 5 (6.0%)         3 (3.5%)        3 (3.6%)      
        VOMITING                                                                               5 (6.0%)         2 (2.3%)        3 (3.6%)      
      SMQ2                                                                                                                                    
        Total number of patients with at least one adverse event related to study drug         5 (6.0%)         2 (2.3%)        3 (3.6%)      
        Total number of events related to study drug                                              6                2                4         
        VOMITING                                                                               5 (6.0%)         2 (2.3%)        3 (3.6%)      
      SMQ3                                                                                                                                    
        Total number of patients with at least one adverse event related to study drug         3 (3.6%)         3 (3.5%)        2 (2.4%)      
        Total number of events related to study drug                                              6                4                2         
        HEADACHE                                                                               3 (3.6%)         3 (3.5%)        2 (2.4%)      

